Literature DB >> 16959942

[D-Trp8]-gamma-melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse).

Stephen J Getting1, Connie W Lam, Giovanna Leoni, Felicity N E Gavins, Paolo Grieco, Mauro Perretti.   

Abstract

Two melanocortin receptors (MC1 and MC3R) have been identified as main transducers of the anti-inflammatory effects of natural and synthetic melanocortins. In this study, we have taken advantage of the recent description of the selective MC3R agonist [d-Trp(8)]-gamma-melanocyte-stimulating hormone (MSH) and of the recessive yellow (e/e) mouse, bearing a nonfunctional MC1R, thereby incrementing our knowledge on this topic. Culturing peritoneal macrophages of recessive yellow (e/e) mice with [d-Trp(8)]-gamma-MSH led to accumulation of cAMP, indicating MC3R receptor functionality: this effect was blocked by a neutralizing antibody against MC3R. Likewise, release of the chemokine KC by urate crystals was attenuated by [d-Trp(8)]-gamma-MSH, and this effect was prevented by synthetic [Ac-Nle(4)-c[Asp(5)-2'-Nal(7),Lys(10)]alpha-MSH(4-10)-NH(2) (SHU9119)] and natural [agouti-related protein (AGRP)] MC3R antagonists but not by the MC4R antagonist Ac-Cys-Nle-Arg-His-d-2-Nal-Arg-Trp-Cys-NH(2) (HS024). Systemic treatment of mice with [d-Trp(8)]-gamma-MSH inhibited KC release and polymorphonuclear cell accumulation elicited by urate crystals in the murine peritoneal cavity. SHU9119 and AGRP prevented the inhibitory actions of [d-Trp(8)]-gamma-MSH, whereas HS024 was inactive. We also demonstrate here that [d-Trp(8)]-gamma-MSH displays a dual mechanism of action by inducing the anti-inflammatory protein heme-oxygenase 1 (HO-1). Treatment with the HO-1 inhibitor zinc protoporphyrin IX exacerbated the inflammatory response elicited by urate crystals and abrogated the anti-inflammatory effects of [d-Trp(8)]-gamma-MSH. In conclusion, these data support the development of the selective MC3R agonist [d-Trp(8)]-gamma-MSH for the treatment of inflammatory pathologies, based on a dual mechanism of cytokine/chemokine inhibition and induction of the anti-inflammatory protein HO-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959942     DOI: 10.1124/mol.106.028878

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-α activated human C-20/A4 chondrocytes.

Authors:  Magdalena K Kaneva; Mark J P Kerrigan; Paolo Grieco; G Paul Curley; Ian C Locke; Stephen J Getting
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Polymorphisms in MC3R promoter and CTSZ 3'UTR are associated with tuberculosis susceptibility.

Authors:  Lindsey A Adams; Marlo Möller; Almut Nebel; Stefan Schreiber; Lize van der Merwe; Paul D van Helden; Eileen G Hoal
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

3.  γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.

Authors:  Christine G Joseph; Hua Yao; Joseph W Scott; Nicholas B Sorensen; Rebecca N Marnane; Kathleen G Mountjoy; Carrie Haskell-Luevano
Journal:  Peptides       Date:  2010-09-15       Impact factor: 3.750

4.  The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature.

Authors:  G Leoni; M-B Voisin; K Carlson; Sj Getting; S Nourshargh; M Perretti
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 5.  Physiological roles of the melanocortin MC₃ receptor.

Authors:  Benjamin J Renquist; Rachel N Lippert; Julien A Sebag; Kate L J Ellacott; Roger D Cone
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

Review 6.  Role of melanocortin receptors in the regulation of gouty inflammation.

Authors:  Trinidad Montero-Melendez; Hetal B Patel; Mauro Perretti
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

7.  Melanocortin receptor expression is associated with reduced CRP in response to resistance training.

Authors:  Tara M Henagan; Laura Forney; Marilyn A Dietrich; Brian R Harrell; Laura K Stewart
Journal:  J Appl Physiol (1985)       Date:  2012-06-07

8.  Functions of acidic transmembrane residues in human melanocortin-3 receptor binding and activation.

Authors:  Shu-Xiu Wang; Zhen-Chuan Fan; Ya-Xiong Tao
Journal:  Biochem Pharmacol       Date:  2008-07-09       Impact factor: 5.858

9.  Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion.

Authors:  Giovanna Leoni; Hetal B Patel; André L F Sampaio; Felicity N E Gavins; Joanne F Murray; Paolo Grieco; Stephen J Getting; Mauro Perretti
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

10.  Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides.

Authors:  Tazeen J Ahmed; Trinidad Montero-Melendez; Mauro Perretti; Costantino Pitzalis
Journal:  Int J Inflam       Date:  2013-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.